The role of place in shaping contraceptive use among women in Africa.

by K Miriam Elfstrom, Rob Stephenson
Published 2012-01-01

Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?

by Karin Sundström, K Miriam Elfström
Published 2020-01-01

Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach.

by Helen C Johnson, K Miriam Elfström, W John Edmunds
Published 2012-01-01

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.

by Maria Persson, K Miriam Elfström, Sven-Erik Olsson, Joakim Dillner, Sonia Andersson
Published 2015-01-01

Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-ba...

by Maria Persson, K Miriam Elfström, Sophia Brismar Wendel, Elisabete Weiderpass, Sonia Andersson
Published 2014-01-01

Cervical cancer screening in Sweden 2014-2016.

by Maria Hortlund, K Miriam Elfström, Pär Sparén, Pouran Almstedt, Björn Strander, Joakim Dillner
Published 2018-01-01

Correction: Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years.

by Ellinor Östensson, Susanna Alder, K Miriam Elfström, Karin Sundström, Niklas Zethraeus, Marc Arbyn, Sonia Andersson
Published 2015-01-01

Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.

by Ellinor Östensson, Susanna Alder, K Miriam Elfström, Karin Sundström, Niklas Zethraeus, Marc Arbyn, Sonia Andersson
Published 2015-01-01

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.

by Jiangrong Wang, Bengt Andrae, Karin Sundström, Alexander Ploner, Peter Ström, K Miriam Elfström, Joakim Dillner, Pär Sparén
Published 2017-10-01

The cost-effectiveness of prostate cancer screening using the Stockholm3 test.

by Andreas A Karlsson, Shuang Hao, Alexandra Jauhiainen, K Miriam Elfström, Lars Egevad, Tobias Nordström, Emelie Heintz, Mark S Clements
Published 2021-01-01

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.

by Jiayao Lei, Alexander Ploner, Camilla Lagheden, Carina Eklund, Sara Nordqvist Kleppe, Bengt Andrae, K Miriam Elfström, Joakim Dillner, Pär Sparén, Karin Sundström
Published 2018-10-01

Differences in risk for SARS-CoV-2 infection among healthcare workers

by K. Miriam Elfström, Jonas Blomqvist, Peter Nilsson, Sophia Hober, Elisa Pin, Anna Månberg, Ville N. Pimenoff, Laila Sara Arroyo Mühr, Kalle Conneryd Lundgren, Joakim Dillner
Published 2021-12-01

Type-specific human papillomavirus biological features: validated model-based estimates.

by Iacopo Baussano, K Miriam Elfström, Fulvio Lazzarato, Anna Gillio-Tos, Laura De Marco, Francesca Carozzi, Francesca Carozzi, Annarosa Del Mistro, Joakim Dillner, Silvia Franceschi, Guglielmo Ronco
Published 2013-01-01

Antibodies to SARS-CoV-2 and risk of past or future sick leave

by Joakim Dillner, K. Miriam Elfström, Jonas Blomqvist, Carina Eklund, Camilla Lagheden, Sara Nordqvist-Kleppe, Cecilia Hellström, Jennie Olofsson, Eni Andersson, August Jernbom Falk, Sofia Bergström, Emilie Hultin, Elisa Pin, Anna Månberg, Peter Nilsson, My Hedhammar, Sophia Hober, Johan Mattsson, Laila Sara Arroyo Mühr, Kalle Conneryd Lundgren
Published 2021-03-01